Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
3 pending office actions • 3 art units • 3 examiners • 0 of 3 (0%) have an AI response strategy ready
Rochal Technologies LLC currently manages 2 pending office actions within the Biotechnology & Pharmaceuticals technology area. These matters are assigned to 2 distinct examiners, resulting in a unique examiner for every pending action. This distribution shows no consolidation of cases under any single examiner for the 2 active matters. This decentralized approach means that the company's pharmaceutical innovations are subject to the individual interpretations of 2 different examiners, requiring a flexible prosecution strategy for each application.
The company's prosecution is active in 2 distinct art units. With 2 pending office actions, each matter is being reviewed by a different specialized group. This distribution across 2 art units indicates that the company's pharmaceutical innovations fall into different technical classifications. The ratio of 2 actions to 2 art units shows that the company's filings are technically diverse, with no consolidation within any single specialized examination group, requiring the company to manage its intellectual property across different technical silos within the biotechnology sector.
LI N KOMATSU is the busiest examiner for the portfolio, currently handling 1 pending office action. Since both distinct examiners are managing 1 action each, the workload is evenly distributed. The management of 2 pending actions across 2 art units reflects the company's current patent prosecution efforts. This balanced distribution across 2 examiners and 2 art units highlights the varied nature of the company's ongoing research and development efforts in the pharmaceutical sector.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (33%) |
| §102 only | 1 (33%) |
| Multi-statute (no §101) | 1 (33%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| KOMATSU, LI N | 1 | 59.8% | +71.1% |
| GOUGH, TIFFANY MAUREEN | 1 | 31.6% | +46.8% |
| BOWLES, DAVID PAUL | 1 | 72.7% | +22.4% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19416925 | AMYLASE COMPOSITIONS FOR PRODUCING COLLAGEN PEPTIDES AND METHODS OF FORMING COLLAGEN PEPTIDES | GOUGH, TIFFANY MAUREEN | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19422266 | HYDROXYPROLINE-FREE HYDROLYZED COLLAGEN PEPTIDES AND METHODS OF MAKING AND USING THE SAME | KOMATSU, LI N | — |
| 19416925 | AMYLASE COMPOSITIONS FOR PRODUCING COLLAGEN PEPTIDES AND METHODS OF FORMING COLLAGEN PEPTIDES | GOUGH, TIFFANY MAUREEN | — |
| 19328859 | ANTIMICROBIAL HYDROLYZED COLLAGEN WITH POLYLYSINE AND METHODS OF USING THE SAME | BOWLES, DAVID PAUL | — |
| Art Unit | Apps |
|---|---|
| 1658 | 1 |
| 1651 | 1 |
| 1654 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19422266 | HYDROXYPROLINE-FREE HYDROLYZED COLLAGEN PEPTIDES AND METHODS OF MAKING AND USING THE SAME | KOMATSU, LI N | 1658 | §102 | Non-Final OA | — | Pending | Dec 16, 2025 |
| 19416925 | AMYLASE COMPOSITIONS FOR PRODUCING COLLAGEN PEPTIDES AND METHODS OF FORMING COLLAGEN PEPTIDES | GOUGH, TIFFANY MAUREEN | 1651 | §102§103§112 | Non-Final OA | — | Pending | Dec 11, 2025 |
| 19328859 | ANTIMICROBIAL HYDROLYZED COLLAGEN WITH POLYLYSINE AND METHODS OF USING THE SAME | BOWLES, DAVID PAUL | 1654 | §103 | Non-Final OA | — | Pending | Sep 15, 2025 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial